KTP - Target Healthcare Limited. Development of platform capability and creation of a robust framework for the assessment of shelf life and stability of a range of aseptically prepared Monoclonal Anti-Bodies (MABs) for patient use.

  • Perrie, Yvonne (Principal Investigator)
  • Halbert, Gavin (Co-investigator)

Project: Research

Project Details

StatusFinished
Effective start/end date24/10/2223/10/24

Funding

  • Target Healthcare Limited
  • Innovate UK: £98,393.00